69 related articles for article (PubMed ID: 12162882)
1. Effect of coadministration of M-CSF and IFN-alpha on NK1.1+ cells in mice.
Sakurai T; Misawa E; Tanaka-Douzono M; Hagesita H; Nomaguchi K; Tetsuya K; Suzu S; Yamada M; Hayasawa H; Motoyoshi K
J Interferon Cytokine Res; 2002 Jun; 22(6):701-8. PubMed ID: 12162882
[TBL] [Abstract][Full Text] [Related]
2. Effects of macrophage colony-stimulating factor and interleukin-2 administration on NK1.1(+) cells in mice.
Misawa E; Sakurai T; Yamada M; Hayasawa H; Motoyoshi K
Int J Immunopharmacol; 2000 Nov; 22(11):967-77. PubMed ID: 11090705
[TBL] [Abstract][Full Text] [Related]
3. Administration of macrophage colony-stimulating factor mobilized both CD11b+CD11c+ cells and NK1.1+ cells into peripheral blood.
Misawa E; Sakurai T; Yamada M; Tamura Y; Motoyoshi K
Int Immunopharmacol; 2004 Jun; 4(6):791-803. PubMed ID: 15135320
[TBL] [Abstract][Full Text] [Related]
4. Booster effect of interleukin-2 on natural killer 1.1+ cells stimulated by administration of macrophage colony-stimulating factor in mice.
Misawa E; Sakurai T; Yamada M; Hayasawa H; Motoyoshi K
J Immunother; 2003; 26(1):21-30. PubMed ID: 12514426
[TBL] [Abstract][Full Text] [Related]
5. Effects of macrophage-colony-stimulating factor on cyclophosphamide-injected mouse NK1.1+ cell activity.
Sakurai T; Misawa E; Yamada M; Hayasawa H; Motoyoshi K
Cancer Immunol Immunother; 2000 May; 49(2):94-100. PubMed ID: 10823419
[TBL] [Abstract][Full Text] [Related]
6. Comparative study and effects of macrophage colony-stimulating factor (M-CSF) administration on NK1.1+ cells in mouse spleen and bone marrow.
Sakurai T; Misawa E; Yamada M; Hayasawa H; Motoyoshi K
Immunopharmacol Immunotoxicol; 2002 Nov; 24(4):547-66. PubMed ID: 12510790
[TBL] [Abstract][Full Text] [Related]
7. Antitumor protection from the murine T-cell leukemia/lymphoma EL4 by the continuous subcutaneous coadministration of recombinant macrophage-colony stimulating factor and interleukin-2.
Vallera DA; Taylor PA; Aukerman SL; Blazar BR
Cancer Res; 1993 Sep; 53(18):4273-80. PubMed ID: 8364923
[TBL] [Abstract][Full Text] [Related]
8. Effect of macrophage colony-stimulating factor on mouse NK 1.1+ cell activity in vivo.
Sakurai T; Wakimoto N; Yamada M; Shimamura S; Motoyoshi K
Int J Immunopharmacol; 1998 Aug; 20(8):401-13. PubMed ID: 9778101
[TBL] [Abstract][Full Text] [Related]
9. Cytokine production-suppressive effect by macrophage colony-stimulating factor (M-CSF).
Kojima K; Naomoto Y; Hizuta A; Tanaka N; Orita K
Res Commun Mol Pathol Pharmacol; 1996 Feb; 91(2):161-72. PubMed ID: 8832908
[TBL] [Abstract][Full Text] [Related]
10. IFN-producing killer dendritic cells contribute to the inhibitory effect of poly I:C on the progression of murine melanoma.
Jiang Q; Wei H; Tian Z
J Immunother; 2008; 31(6):555-62. PubMed ID: 18528299
[TBL] [Abstract][Full Text] [Related]
11. Biological and antitumor effects of recombinant human macrophage colony-stimulating factor in mice.
Bock SN; Cameron RB; Kragel P; Mulé JJ; Rosenberg SA
Cancer Res; 1991 May; 51(10):2649-54. PubMed ID: 2021943
[TBL] [Abstract][Full Text] [Related]
12. Synergy between recombinant human IL-1 alpha (rHuIL-1) and M-CSF (rHuM-CSF) during the recovery of murine hematopoietic activity in myelosuppressed animals: abbreviated versus chronic administration of rHuM-CSF.
Kovacs CJ; Harrell JP; Gooya JM; Evans MJ; Johnke RM
Exp Hematol; 1992 Jun; 20(5):582-9. PubMed ID: 1587305
[TBL] [Abstract][Full Text] [Related]
13. Antimetastatic effect of recombinant human macrophage-colony-stimulating factor against lung and liver metastatic B16 melanoma.
Sakurai T; Yamada M; Simamura S; Motoyoshi K
Cancer Immunol Immunother; 1997 Mar; 44(1):48-54. PubMed ID: 9111584
[TBL] [Abstract][Full Text] [Related]
14. Effect of macrophage colony-stimulating factor (M-CSF) on mouse immune responses in vivo.
Sakurai T; Wakimoto N; Yamada M; Shimamura S; Motoyoshi K
Immunopharmacol Immunotoxicol; 1998 Feb; 20(1):79-102. PubMed ID: 9543701
[TBL] [Abstract][Full Text] [Related]
15. Activation of mouse liver natural killer cells and NK1.1(+) T cells by bacterial superantigen-primed Kupffer cells.
Dobashi H; Seki S; Habu Y; Ohkawa T; Takeshita S; Hiraide H; Sekine I
Hepatology; 1999 Aug; 30(2):430-6. PubMed ID: 10421651
[TBL] [Abstract][Full Text] [Related]
16. Antitumor effect of interleukin 7 in combination with local hyperthermia in mice bearing B16a melanoma cells.
Wu B; Shen RN; Wang WX; Broxmeyer HE; Lu L
Stem Cells; 1993 Sep; 11(5):412-21. PubMed ID: 8241952
[TBL] [Abstract][Full Text] [Related]
17. Potentiation of antitumor effects of tumor necrosis factor alpha and interferon gamma by macrophage-colony-stimulating factor in a MmB16 melanoma model in mice.
Lasek W; Wańkowicz A; Kuc K; Feleszko W; Gołab J; Giermasz A; Wiktor-Jedrzejczak W; Jakóbisiak M
Cancer Immunol Immunother; 1995 May; 40(5):315-21. PubMed ID: 7600564
[TBL] [Abstract][Full Text] [Related]
18. In vivo effects of purified recombinant human macrophage colony-stimulating factor in combination with local hyperthermia on tumor progression in B16a melanoma bearing mice.
Lu L; Xiao M; Wu B; Wang WX; Yan WR; Broxmeyer HE; Shen RN
Int J Hematol; 1993 Oct; 58(3):139-52. PubMed ID: 8148492
[TBL] [Abstract][Full Text] [Related]
19. Anti-tumor effects of recombinant human macrophage colony-stimulating factor, alone or in combination with local irradiation, in mice inoculated with Lewis lung carcinoma cells.
Lu L; Shen RN; Lin ZH; Aukerman SL; Ralph P; Broxmeyer HE
Int J Cancer; 1991 Jan; 47(1):143-7. PubMed ID: 1985870
[TBL] [Abstract][Full Text] [Related]
20. Enhanced suppression of pulmonary metastasis of malignant melanoma cells by combined administration of alpha-galactosylceramide and interleukin-18.
Nishio S; Yamada N; Ohyama H; Yamanegi K; Nakasho K; Hata M; Nakamura Y; Fukunaga S; Futani H; Yoshiya S; Ueda H; Taniguchi M; Okamura H; Terada N
Cancer Sci; 2008 Jan; 99(1):113-20. PubMed ID: 17949451
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
